Timothy Scannell, Director at NovoCure, holds 25.90K shares in NovoCure (Ticker: NVCR), holds ― shares in Molekule Group (Ticker: MKULQ), holds 0.00 shares in Masimo (Ticker: MASI).
Timothy Scannell latest transaction was an Uninformative Buy of ―.
What was Timothy Scannell's most profitable transaction?
Timothy Scannell’s most profitable transaction was an Informative Sell of NVCR stock on June 6, 2024. The return on the trade was 23.20%.
What is Timothy Scannell's role in NovoCure?
Timothy Scannell's role in NovoCure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.